How This Evidence Evolved
AAA Repair: Open vs Endovascular
From Open Surgical Repair to EVAR and the Long-Term Equipoise Debate
Timeline
Early observations and pilot data that first suggested a new direction
Landmark RCTs and pivotal trials that established the evidence base
30-day operative mortality: EVAR 1.7% vs open 4.7% (OR 0.35, 95% CI 0.16-0.77; P=.009)
Operative mortality at 30 days: open 4.6% vs EVAR 1.2% (RR 3.9, 95% CI 0.9–32.9).
Perioperative mortality (30 days or inpatient): EVAR 0.5% vs open 3.0% (P=.004); mortality at 2 years 7.0% vs 9.8% (P=.13)
Operative mortality at 30 days: open 4.6% vs EVAR 1.2% (RR 3.9, 95% CI 0.9-32.9)
Follow-up studies, subgroup analyses, and real-world validation
Mortality beyond 8 years, EVAR vs open: all-cause adjusted HR 1.25 (95% CI 1.00-1.56; P=.048); aneurysm-related HR 5.82 (1.64-20.65; P=.0064)
All-cause mortality through up to 14 years: EVAR 68.0% vs open 70.0% (HR 0.96, 95% CI 0.82–1.13).
All-cause mortality through up to 14 years: EVAR 68.0% vs open 70.0% (HR 0.96, 95% CI 0.82-1.13)
Total mortality during follow-up through 2009: EVAR vs no repair adjusted HR 0.99 (95% CI 0.78-1.27; P=.97); aneurysm mortality HR 0.53 (0.32-0.89; P=.02)
Type I endoleak within 1 year: hostile vs favorable neck anatomy OR 4.563 (95% CI 1.430-14.558)
Mortality at higher-volume hospitals: elective repair OR 0.66 (95% CI 0.65-0.67), threshold 43 per year; ruptured repair OR 0.78 (0.73-0.82), threshold 15 per year
Current standard of care and ongoing research directions
Landmark Trials in This Story
Transfemoral intraluminal graft implantation for abdominal aortic aneurysms
Technical success of endovascular graft deployment
Comparison of endovascular aneurysm repair with open repair in patients with abdominal aortic aneurysm (EVAR trial 1), 30-day operative mortality results: randomised controlled trial.
30-day operative mortality: EVAR 1.7% vs open 4.7% (OR 0.35, 95% CI 0.16-0.77; P=.009)
A randomized trial comparing conventional and endovascular repair of abdominal aortic aneurysms.
Operative mortality at 30 days: open 4.6% vs EVAR 1.2% (RR 3.9, 95% CI 0.9–32.9).
Outcomes following endovascular vs open repair of abdominal aortic aneurysm: a randomized trial.
Perioperative mortality (30 days or inpatient): EVAR 0.5% vs open 3.0% (P=.004); mortality at 2 years 7.0% vs 9.8% (P=.13)
A randomized trial comparing conventional and endovascular repair of abdominal aortic aneurysms.
Operative mortality at 30 days: open 4.6% vs EVAR 1.2% (RR 3.9, 95% CI 0.9-32.9)
Endovascular versus open repair of abdominal aortic aneurysm in 15-years' follow-up of the UK endovascular aneurysm repair trial 1 (EVAR trial 1): a randomised controlled trial.
Mortality beyond 8 years, EVAR vs open: all-cause adjusted HR 1.25 (95% CI 1.00-1.56; P=.048); aneurysm-related HR 5.82 (1.64-20.65; P=.0064)
Open versus Endovascular Repair of Abdominal Aortic Aneurysm.
All-cause mortality through up to 14 years: EVAR 68.0% vs open 70.0% (HR 0.96, 95% CI 0.82–1.13).
Open versus Endovascular Repair of Abdominal Aortic Aneurysm.
All-cause mortality through up to 14 years: EVAR 68.0% vs open 70.0% (HR 0.96, 95% CI 0.82-1.13)
Endovascular repair of aortic aneurysm in patients physically ineligible for open repair.
Total mortality during follow-up through 2009: EVAR vs no repair adjusted HR 0.99 (95% CI 0.78-1.27; P=.97); aneurysm mortality HR 0.53 (0.32-0.89; P=.02)
A meta-analysis of outcomes of endovascular abdominal aortic aneurysm repair in patients with hostile and friendly neck anatomy.
Type I endoleak within 1 year: hostile vs favorable neck anatomy OR 4.563 (95% CI 1.430-14.558)
Meta-analysis and systematic review of the relationship between volume and outcome in abdominal aortic aneurysm surgery.
Mortality at higher-volume hospitals: elective repair OR 0.66 (95% CI 0.65-0.67), threshold 43 per year; ruptured repair OR 0.78 (0.73-0.82), threshold 15 per year
Explore the evidence yourself
Ask AttendMe about any trial, guideline, or clinical question. Evidence-ranked answers from 3.7M+ peer-reviewed articles.